Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov;24(45):1900655.
doi: 10.2807/1560-7917.ES.2019.24.45.1900655.

Vector-borne transmission of Zika virus in Europe, southern France, August 2019

Sandra Giron  1 , Florian Franke  1 , Anne Decoppet  2 , Bernard Cadiou  3 , Thierry Travaglini  3 , Laurence Thirion  4 , Guillaume Durand  4   5 , Charles Jeannin  3 , Grégory L'Ambert  3 , Gilda Grard  4   5 , Harold Noël  6 , Nelly Fournet  6 , Michelle Auzet-Caillaud  2 , Christine Zandotti  5 , Samer Aboukaïs  2 , Pascal Chaud  1 , Saby Guedj  7 , Lakri Hamouda  7 , Xavier Naudot  8 , Anne Ovize  8 , Clément Lazarus  9 , Henriette de Valk  6 , Marie-Claire Paty  6 , Isabelle Leparc-Goffart  4   5
Affiliations

Vector-borne transmission of Zika virus in Europe, southern France, August 2019

Sandra Giron et al. Euro Surveill. 2019 Nov.

Abstract

On 1 October 2019, a locally-acquired Zika virus disease case was laboratory confirmed in Hyères, Var department. Active case finding identified two additional locally-acquired cases living within 90 m, with symptom onset 8 days before the index case. Extensive patient interviews did not yield information supporting transmission through sexual contact or substances of human origin. Vector-borne transmission by local Aedes albopictus mosquitoes is the most likely mode of transmission. Here we describe the public health response.

Keywords: Aedes albopictus; France; Zika virus; vector-borne transmission.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

References

    1. Musso D, Ko AI, Baud D. Zika Virus Infection - After the Pandemic. N Engl J Med. 2019;381(15):1444-57. 10.1056/NEJMra1808246 - DOI - PubMed
    1. Agence Régionale de Santé PACA Délégation départementale du Var. Plan de lutte contre la propagation des maladies vectorielles transmises par Aedes albopictus: chikungunya, dengue et Zika dans le département du Var pour 2018. RAA N°20 spécial du 6 avril 2018. [Response plan against the spread of vector-borne diseases transmitted by Aedes albopictus: chikungunya, dengue and Zika, Var department, 2018. RAA N° 20 special on 6 April 2018]. Toulon: Agence Régionale de Santé PACA, délégation départementale du Var; 3 Apr 2019. French. Available from: https://www.paca.ars.sante.fr/system/files/2018-09/APLAV18_83_ars_paca_1...
    1. Hoen B, Schaub B, Funk AL, Ardillon V, Boullard M, Cabié A, et al. Pregnancy outcomes after ZIKV infection in French territories in the Americas. N Engl J Med. 2018;378(11):985-94. 10.1056/NEJMoa1709481 - DOI - PubMed
    1. Pomar L, Vouga M, Lambert V, Pomar C, Hcini N, Jolivet A, et al. Maternal-fetal transmission and adverse perinatal outcomes in pregnant women infected with Zika virus: prospective cohort study in French Guiana. BMJ. 2018;363:k4431. 10.1136/bmj.k4431 - DOI - PMC - PubMed
    1. Musso D, Stramer SL, Busch MP, AABB Transfusion-Transmitted Diseases Committee. International Society of Blood Transfusion Working Party on Transfusion-Transmitted Infectious Diseases Zika virus: a new challenge for blood transfusion. Lancet. 2016;387(10032):1993-4. 10.1016/S0140-6736(16)30428-7 - DOI - PubMed

LinkOut - more resources